Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma

Annunziata De Luisi(University of Bari Aldo Moro), Doménico Ribatti(University of Bari Aldo Moro), Roberto Ria(University of Bari Aldo Moro), Simona Ruggieri(University of Bari Aldo Moro), Simona Berardi(Swiss Group For Clinical Cancer Research), Vincenzo Pavone, Ivana Catacchio(University of Bari Aldo Moro), Laura Binetti(University of Bari Aldo Moro), Vito Racanelli(University of Trento), Bernardo Rossini(Istituto Tumori Bari), Angelo Vacca(University of Bari Aldo Moro)

Angiogenesis

July 24, 2013

10.1007/s10456-013-9369-2

Cited by 26

Related Papers

Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.

|PubMed|1997|279

Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

|Blood|2011|268

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

|Blood|2008|253

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

|Journal of Clinical Oncology|2014|210

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

|Arthritis & Rheumatology|2021|165